Industry News

The Industry News page consists of Industry Spotlights, Pre-Event Newsletters, Post-Event Reports, Whitepapers and Vendor News.

Industry Spotlight
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
Edited by Tom Cohen |
14 November 2023
Therapeutic Modalities
Industry Spotlight
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Edited by Guillaume Alonso |
14 November 2023
Tumour Microenvironment, Immuno Series
Industry Spotlight
Compugen's candidate therapeutic, COM503, targets interleukin-18 binding protein to unleash interleukin-18's immunostimulatory power.
13 November 2023
Tumour Microenvironment
Industry Spotlight
TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.
Edited by Tom Cohen |
07 November 2023
Tumour Microenvironment
Industry Spotlight
Talking with Laura von Schantz, Chief Technology Officer, at Alligator Biosciences about their RUBY bispecific antibody format.
Edited by Tom Cohen |
02 November 2023
Therapeutic Modalities
Whitepaper
Nanion Technologies GmbH, Munich. TUM, Munich
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Uniquely designed for clinical research.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Welcome to the next level of live-cell analytics.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Next level live-cell kinetic and phenotypic assays.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Unprecedented flexibility for HTS automated patch clamp.
01 November 2023
Biomarkers in Immuno-Oncology
Advertisement